BRIEF-Ironwood Pharmaceuticals Q4 Revenue USD 47.709 Million
Reuters02-25
BRIEF-Ironwood Pharmaceuticals Q4 Revenue USD 47.709 Million
Feb 25 (Reuters) - Ironwood Pharmaceuticals Q4 adjusted net income USD -2.274 million.
Q4 adjusted EBITDA USD 10.913 million
Q4 basic EPS USD -0.01
Q4 net income USD -2.276 million
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments